Alterations in surface hydrophobicity of Acinetobacter baumannii induced by meropenem

Folia Microbiologica

Volumn 44, Issue 3, 1999, Pages 267-270

  Hostacka A ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS);

MEROPENEM; THIENAMYCIN DERIVATIVE; XYLENE;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ADHERENCE; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; MICROBIOLOGICAL EXAMINATION; PATHOGENICITY; SURFACE PROPERTY;

ACINETOBACTER; BACTERIAL ADHESION; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; SURFACE PROPERTIES; THIENAMYCINS; XYLENES;

EID: 0033255210     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02818545     Document Type: Article

References (29)

1. BELLO H., GONZALES G., DOMINGUEZ M., ZEMELMAN R., GARCIA A., MELLA S.: Activity of selected β-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals. Diagn.Microbiol.Infect.Dis. 28, 183-186 (1997).
2. BERGOGNE-BÉRÉZIN E., JOLY-GUILLOU M.L., VIEU J.F.: Epidemiology of nosocomial infections due to Acinetobacter calcoaceticus. J.Hosp.Infect. 10, 105-113 (1987).
3. BRAGA P.C., DAL SASSO M., MACI S., REGGIO S., PIATTI G.: Influence of subinhibitory concentrations of brodimoprim and trimethoprim on the adhesiveness, hydrophobicity, hemagglutination and motility of Escherichia coli. Chemotherapy 41, 50-58 (1995).
4. BUISSON Y., TRAN VAN NHIEU G., GINOT L., BOUVET P., SCHILL H., DRIOT L. MEYRAN M.: Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage. J.Hosp.Infect. 15, 83-93 (1990).
5. CROWE M., TOWNER K.J., HUMPHREYS H.: Clinical and epidemiological features of an outbreak of Acinetobacter infection in an intensive therapy unit. J.Med.Microbiol. 43, 55-62 (1995).
6. DESNOTTES J.F., DIALLO N., MORET G., SANTONJA R.: Effects of subinhibitory concentrations of pefloxacin on the adherence of S. aureus to human cell. Drug.Exp.Clin.Res. 13, 69-73 (1987).
7. EDWARDS J.R., WILLIAMS S., NAIRN K.: Therapeutic activity of meropenem in experimental infections. J.Antimicrob.Chemother. 24 (Suppl. A), 279-286 (1989).
8. FRENCH G.L., CASEWELL M.W., RONCORONI A.J., KNIGHT S., PHILIPS I.: A hospital outbreak of antibiotic-resistant Acinetobacter anitratus: epidemiology and control. J.Hosp.Infect. 1, 125-131 (1980).
9. GRIMWOOD K., TO M., RABIN H.R., WOODS D.E.: Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrob.Agents Chemother. 33, 41-47 (1989).
10. GRISTINA A.G.: Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237, 1588-1595 (1987).
11. HOŠTACKÁ A.: Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones. Microbios 91, 137-143 (1997).
12. JONES R.N., BARRY A.L., THORNSBERRY G.: In vitro studies of meropenem. J.Antimicrob.Chemother. 24 (Suppl. A), 9-29 (1989).
13. KADURUGAMUWA J.L., ANWAR H., BROWN M.R.W., ZAK O.: Effect of subinhibitory concentrations of cephalosporins on surface properties and siderophore production in iron-depleted Klebsiella pneumoniae. Antimicrob.Agents Chemother. 27, 220-223 (1985).
14. MOKADDAS E.M., SANYAL S.C.: Imipenem resistance in aerobic gramnegative bacteria. J.Chemother. 10, 97-101 (1998).
15. MORGAN M.E.J., HART C.A.: Acinetobacter meningitis: acquired infections in a neonatal intensive care unit. Arch.Dis.Child. 57, 557-559 (1982).
16. MULIN B., TALON D., VIEL J.F., VINCENT C., LEPRAT R., THOUVEREZ M., MICHEL-BRIAND Y.: Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii. Eur.J.Clin.Microbiol.Infect.Dis. 14, 569-576 (1995).
17. NOMURA S., NAGAYAMA A.: Mechanisms of enhancement of bactericidal activity of phagocytoses against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime. Chemotherapy 41, 267-275 (1995).
18. PATON R., MILES R.S., HOOD J., AMYES S.G.B.: ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Internat.J.Antimicrob.Agents 2, 81-88 (1993).
19. ROSENBERG M., GUTNICK D., ROSENBERG E.: Adherence of bacteria to hydrocarbons: a simple method for measuring cell-surface hydrophobicity. FEMS Microbiol.Lett. 9, 29-33 (1980).
20. SEIFERT H., BAGINSKI R., SCHULTZE A., PULVERER G.: Antimicrobial susceptibility of Acinetobacter species. Antimicrob.Agents Chemother. 37, 750-753 (1993).
21. STRUELENS M.J., CARLIER E., MAES N., SERRUYS E., QUINT W.G.V., VAN BELKUM A.: Nosocomial colonisation and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting.J.Hosp.Infect. 25, 15-32 (1993).
22. TATEDA K., HIRAKATA Y., FURUYA N., OHNO A., YAMAGUCHI K.: Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa. Antimicrob.Agents Chemother. 37, 675-680 (1993).
23. TATEDA K., YOSHIKAZU I., HIRAKATA Y., MATSUMOTO T., OHNO A., YAMAGUCHI K.: Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity. J.Antimicrob.Chemother. 34, 931-942 (1994).
24. TAWFIK A.F., RAMADAN M.A., SHIBL A.M.: Inhibition of motility and adherence of Proteus mirabilis to uroepithelial cells by subinhibitory concentrations of amikacin. Chemotherapy 43, 424-429 (1997).
25. TILLEY P.A.G., ROBERTS F.J.: Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clin.Infect.Dis. 18, 896-900 (1994).
26. VAN LOOSDRECHT M.C.M., VAN LYKLEMA J., NORDE W., SCHRAA G., ZEHNDER A.J.B.: The role of bacterial cell wall hydrophobicity in adhesion. Appl.Environ.Microbiol. 53, 1893-1897 (1987).
27. VILA J., MARCOS A., MARCO F., ABDALLA S., VERGARA Y., REIG R., GOMES-LUS R., JIMENEZ DE ANTA T.: In vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob.Agents Chemother. 37, 138-141 (1993).
28. WILLIAMS P.: Sub-MICs of cefuroxime and ciprofloxacin influence interaction of complement and immunoglobulins with Klebsiella pneumoniae. Antimicrob.Agents Chemother. 31, 758-762 (1987).
29. ZAK O., KRADOLFER F.: Effects of subminimal inhibitory concentrations of antibiotics in experimental infections. Rev.Infect. Dis. 1, 862-879 (1979).